🇺🇸 FDA
Patent

US 9255250

Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene

granted A61KA61K2035/124A61K35/28

Quick answer

US patent 9255250 (Isolated mouse or human cell having an exogenous transgene in an endogenous albumin gene) held by Sangamo Biosciences, Inc. expires Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Biosciences, Inc.
Grant date
Tue Feb 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2035/124, A61K35/28, A61K48/005, A61P